Benitec Biopharma Inc. (BNTC) Revenue, Earnings & Financial Statements
$8.15NASDAQ: BNTCMarket Cap $284.35M
Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
Benitec Biopharma Inc. most recently reported annual revenue of $0, a net loss of $46.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Benitec Biopharma Inc.: net profit was positive in 1 of 10 reported years; operating margin moved from -8132.4% to -25441.3%, a shift of -17309.0 percentage points; the most recent year shows a net loss of $46.0M.
Income Statement — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Revenue
$0
$4.0M
$17.0M
$0
$0
$0
$0
$0
$0
$0
Operating Expenses
$16.0M
$13.0M
$14.0M
$8.0M
$14.0M
$18.0M
$19.0M
$22.0M
$42.0M
$51.0M
Operating Profit
−$16.0M
−$9.0M
$4.0M
−$8.0M
−$14.0M
−$18.0M
−$19.0M
−$22.0M
−$42.0M
−$51.0M
Operating Margin
-8132.4%
-198.4%
21.2%
-8537.1%
-23044.1%
-24457.5%
-25441.3%
—
—
—
Other Income
$0
$0
$0
$0
$0
$0
$0
$1.0M
$4.0M
$6.0M
Interest
$0
$0
$0
$0
$0
$0
$0
$0
$3.0M
$0
Depreciation
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Profit Before Tax
−$3.0M
−$9.0M
$4.0M
−$8.0M
−$14.0M
−$18.0M
−$20.0M
−$22.0M
−$38.0M
−$46.0M
Tax rate (%)
309.1%
49.2%
-24.8%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Net Profit
−$6.0M
−$12.0M
$4.0M
−$8.0M
−$14.0M
−$18.0M
−$20.0M
−$22.0M
−$38.0M
−$46.0M
EPS
−$63.55
−$103.60
$28.45
−$8.10
−$27.27
−$19.31
−$14.12
−$5.51
−$1.05
−$0.98
Quarterly Results — Last 12 Quarters (USD millions)
8 duplicate period labels in the source data were collapsed.
Metric
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Operating Expenses
$7.0M
$4.0M
$6.0M
$6.0M
$11.0M
$15.0M
$17.0M
$10.0M
$13.0M
$14.0M
$14.0M
$14.0M
Operating Profit
−$7.0M
−$4.0M
−$6.0M
−$6.0M
−$11.0M
−$15.0M
−$17.0M
−$10.0M
−$13.0M
−$14.0M
−$14.0M
−$14.0M
Interest
$0
$0
$0
$1.0M
$0
$0
$0
$0
$1.0M
$0
$0
$0
Profit Before Tax
−$7.0M
−$4.0M
−$5.0M
−$5.0M
−$10.0M
−$15.0M
−$16.0M
−$9.0M
−$12.0M
−$12.0M
−$13.0M
−$13.0M
Tax rate (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Net Profit
−$7.0M
−$4.0M
−$5.0M
−$5.0M
−$10.0M
−$15.0M
−$16.0M
−$9.0M
−$12.0M
−$12.0M
−$13.0M
−$13.0M
EPS
−$0.54
−$0.23
−$0.53
−$0.48
−$0.33
−$0.38
−$0.45
−$0.22
−$0.26
−$0.24
−$0.27
−$0.26
Over the 10 years reported for Benitec Biopharma Inc., cash stood at $180.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 36.40 times.
Balance Sheet — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
$23.0M
$21.0M
$28.0M
$12.0M
$21.0M
$6.0M
$4.0M
$52.0M
$100.0M
$183.0M
Current Assets
$22.0M
$21.0M
$27.0M
$11.0M
$21.0M
$5.0M
$4.0M
$52.0M
$99.0M
$182.0M
Cash
$17.0M
$16.0M
$22.0M
$10.0M
$20.0M
$4.0M
$2.0M
$51.0M
$98.0M
$180.0M
Inventory
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Receivables
$3.0M
$4.0M
$5.0M
$0
$0
$0
$0
$0
$0
$0
Fixed Assets
$0
$0
$0
$1.0M
$1.0M
$1.0M
$1.0M
$0
$1.0M
$1.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Investments
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Other Assets
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Total Liabilities
$1.0M
$3.0M
$3.0M
$2.0M
$1.0M
$3.0M
$4.0M
$5.0M
$2.0M
$6.0M
Current Liabilities
$1.0M
$3.0M
$3.0M
$1.0M
$1.0M
$3.0M
$4.0M
$5.0M
$2.0M
$5.0M
Borrowings
$0
$0
$0
$0
$0
$1.0M
$1.0M
$0
$1.0M
$1.0M
Other Liabilities
$1.0M
$3.0M
$3.0M
$1.0M
$1.0M
$2.0M
$4.0M
$5.0M
$1.0M
$5.0M
Equity
$156.0M
$121.0M
$0
$0
$0
$0
$0
$0
$0
$0
Reserves
$22.0M
$14.0M
$17.0M
$10.0M
$20.0M
$3.0M
$0
$47.0M
$97.0M
$177.0M
For Benitec Biopharma Inc., operating cash flow was positive in 1 of 10 reported years; free cash flow in the latest year was negative at $17.0M; free cash flow was positive in 1 of 10 years.
Cash Flow Statement — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Operating Cash Flow
−$8.0M
−$9.0M
$5.0M
−$8.0M
−$13.0M
−$16.0M
−$18.0M
−$19.0M
−$24.0M
−$17.0M
Investing Cash Flow
$0
$0
−$1.0M
$0
$0
$0
$0
$0
$0
$0
Financing Cash Flow
$2.0M
$2.0M
−$1.0M
$0
−$3.0M
$0
−$2.0M
−$3.0M
$0
$0
Net Cash Flow
−$1.0M
−$1.0M
$4.0M
−$6.0M
$10.0M
−$16.0M
−$2.0M
$48.0M
$47.0M
$82.0M
Free Cash Flow
−$8.0M
−$9.0M
$4.0M
−$8.0M
−$13.0M
−$16.0M
−$18.0M
−$20.0M
−$24.0M
−$17.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
-0.31
EV / EBITDA
-2.59
FCF Yield
-5.50%
Quick Ratio
19.62
Interest Coverage
40.19
Return 1Y
-35.11%
Return 3Y
148.98%
Return 5Y
-85.27%
Benitec Biopharma Inc. (BNTC) financials — frequently asked questions
What is Benitec Biopharma Inc.'s annual revenue?
Benitec Biopharma Inc. (BNTC) reported annual revenue of $0 in its most recent fiscal year.
What is Benitec Biopharma Inc.'s net profit?
Benitec Biopharma Inc. (BNTC) reported a net loss of $46.0M in its most recent fiscal year.
What is BNTC EV/EBITDA?
Benitec Biopharma Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -2.59. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.
Revenue and earnings of other Biotechnology stocks